Effect of Using Pictograms on Improving Depression and Anxiety Among Type 2 Diabetic Patients.

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

204 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-04-01

Study Completion Date

2023-08-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

we will study the impact of using pictograms on improving depression and anxiety among type 2 diabetic patients, we suppose that patients who received pictograms-enriched labels will have lower levels of depression and anxiety in comparison with those who will not receive after three month follow-up evaluation.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Psychological Variables and Hyperglycemia in Diabetes Mellitus

NCT01714986

Diabetes Mellitus Depression Alexithymia +1 more

WITHDRAWN NA

Psychological Impact in Diabetes: Intervention With Affect School and Basal Body Awareness

NCT01498614

Diabetes Mellitus Depression Alexithymia +1 more

TERMINATED NA

A Pilot Study to Assess the Impact of Breath Awareness Using Pyramid on Symptoms of Anxiety and Depression in People with T2DM

NCT06632782

Depression, Anxiety

RECRUITING NA

Evaluation of a Stepped Care Approach to Manage Depression in Diabetes

NCT01812291

Major Depressive Disorder Minor Depressive Disorder Sub-Threshold Depression +1 more

COMPLETED NA

Web-Based Collaborative Care for Patients With Diabetes and Depression

NCT01985711

Diabetes Mellitus, Type 2 Depression

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Type 2 Diabetes

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

intervention group

they will receive the usual diabetes care routine plus a pictogram-enriched label.

Group Type ACTIVE_COMPARATOR

picograms-enriched label

Intervention Type BEHAVIORAL

The intervention care includes usual care (instructions for using each anti-diabetic drug) plus pictograms that show how much medications should be taken at each time of day (morning, noon, evening, and night), how to take them in relation to meals, the purpose of the drug, and the most important non-pharmacologic interventions for diabetic patients (weight loss, exercise, avoiding smoking, blood sugar controlling).

control group

they will receive the usual diabetes care routine.

Group Type PLACEBO_COMPARATOR

picograms-enriched label

Intervention Type BEHAVIORAL

The intervention care includes usual care (instructions for using each anti-diabetic drug) plus pictograms that show how much medications should be taken at each time of day (morning, noon, evening, and night), how to take them in relation to meals, the purpose of the drug, and the most important non-pharmacologic interventions for diabetic patients (weight loss, exercise, avoiding smoking, blood sugar controlling).

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

picograms-enriched label

The intervention care includes usual care (instructions for using each anti-diabetic drug) plus pictograms that show how much medications should be taken at each time of day (morning, noon, evening, and night), how to take them in relation to meals, the purpose of the drug, and the most important non-pharmacologic interventions for diabetic patients (weight loss, exercise, avoiding smoking, blood sugar controlling).

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Participants are eligible if they are Jordanian adults, aged 18 or older, who have been clinically diagnosed with T2DM for at least 6 months, having low health literacy (Individuals who obtained 66 or lower scores in the full TOFHLA instrument are considered as individuals with "low literacy" in the study) \[24\], come personally for the refill.

Exclusion Criteria

* Patients who are unable to communicate verbally (aphasic or with hearing impairment), those with any visual, learning disabilities, and psychological or hepatorenal disease (according to the clinical diagnosis by a physician), and those deemed too ill or frail to attend the clinic, and who have participated in other diabetes education research projects will be excluded.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No